CHESAPEAKE UTILITIES CORPORATION REPORTS THIRD QUARTER 2026 RESULTS

Chesapeake Utilities reported Q3 2026 net income of $21.6 million and diluted EPS of $0.89, versus $19.4 million and $0.82 a year earlier; nine-month adjusted EPS rose 8.4% to $4.40. The company reaffirmed 2026 capital spending guidance of $550–$600 million and 2028 EPS guidance of $7.75–$8.00, and announced a NextEra Energy Resources joint venture to finance and own 49% of a $1.2 billion, 97-mile Florida gas transmission project. It also established an at-the-market program allowing up to $225 million in common-stock sales.

Analysis

The earnings mix is more valuable than the headline growth rate: regulated infrastructure, rate recovery and transmission expansions are doing most of the work, making CPK’s growth less exposed to commodity-price swings but more dependent on timely regulatory recovery and disciplined project execution. The offset is rising capital intensity. The ATM and increased short-term borrowing make funding and dilution a live part of the thesis; the disclosed share issuance already reduced year-to-date EPS growth, and further issuance could absorb some operating upside. Treat the borrowing balance cautiously—it may be seasonal—but verify its trajectory and funding plan.

The NextEra Energy Resources partnership can share financing and execution risk on FEP, but does not establish project returns or eliminate CPK’s retained exposure. Confirm ownership economics, construction milestones and contracted capacity before assigning meaningful value to the project. The December FCG rate-case decision is the nearest earnings catalyst; the February 2027 guidance update will test whether the current growth pipeline supports returns after financing costs and dilution.

Contrarian angle: the market may over-credit multi-year capex as automatic EPS growth. Rate-base additions create value only if regulators permit adequate returns and operating-cost inflation does not outrun recovery. Conversely, a satisfactory FCG order and credible long-range funding plan could make current dilution a temporary cost of compounding regulated earnings. Without valuation and market-reaction data, avoid chasing the release.

Key Decisions for Investors

• Hold or initiate CPK only on weakness pending the November 6 call; do not underwrite FEP as near-term earnings until management clarifies CPK’s retained capital commitment, return profile and contracted volumes.
• Use the December FCG rate decision as the near-term catalyst: positive if final allowed recovery supports the interim increase without material adverse terms; reassess if the order falls short or is delayed.
• Track ATM issuance, short-term borrowing and diluted share count alongside EPS. A rising share count that continues to dilute growth, or borrowing that remains elevated beyond seasonal needs, would weaken the case for adding.
• Revisit the position after February 2027 guidance. Falsify the growth thesis if management lowers its 2028 EPS outlook, cuts the investment plan, or cannot show that new regulated investment earns returns after financing and operating costs.